Patents Assigned to FREQUASENSE LIMITED
  • Point of care sepsis assay device and method
    Patent number: 12135301
    Abstract: The present invention relates generally to the field of disposable assay test devices, particularly for use in point-of-care assays. The invention further relates to the use of such devices, including kits comprising such devices, to facilitate the accurate measurement of the levels of sepsis in the blood using electronic measurements.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: November 5, 2024
    Assignee: FREQUASENSE LIMITED
    Inventors: Phill Ainger, Colin Downey, David George
  • POINT OF CARE SEPSIS ASSAY DEVICE AND METHOD
    Publication number: 20230146070
    Abstract: The present invention relates generally to the field of disposable assay test devices, particularly for use in point-of-care assays. The invention further relates to the use of such devices, including kits comprising such devices, to facilitate the accurate measurement of the levels of sepsis in the blood using electronic measurements.
    Type: Application
    Filed: March 22, 2021
    Publication date: May 11, 2023
    Applicant: FREQUASENSE LIMITED
    Inventors: Phill AINGER, Colin DOWNEY, David GEORGE